AKT1 and hepatocellular carcinoma: MALAT1 is also heavily involved in HBx‐related HCC progression, and silencing MALAT1 can block HBx‐induced CSCs generation, stemness‐related factor activation, and tumorigenicity via the PI3K/AKT signaling [147].